-
Boyce BF. Advances in the regulation of osteoclasts and osteoclast functions. Journal of dental research. 2013 Aug 1:0022034513500306.
View at Publisher | View at Google Scholar
-
Boyce BF. Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts. Journal of Bone and Mineral Research. 2013 Apr 1;28(4):711-22.
View at Publisher | View at Google Scholar
-
Gelman IH. Androgen receptor activation in castration-recurrent prostate cancer: the role of Src-family and Ack1 tyrosine kinases. Int J Biol Sci. 2014 Jan 1;10(6):620-6.
View at Publisher | View at Google Scholar
-
Benz MR, Kemper MJ (2015) Nephrotisches Syndrom im Kindesalter. Monatsschrift Kinderheilkunde 163:310-322. View at Publisher | View at Google Scholar
| View at Indexing
-
Wang SJ, Cui HY, Liu YM, Zhao P, Zhang Y, Fu ZG, Chen ZN, Jiang JL. CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells. Oncotarget. 2015 Jan 1;6(1):243-57.
View at Publisher | View at Google Scholar
-
Benz MR, Ehren R, Tönshoff B, Weber LT (2015) Alternativen zur Steroidbehandlung des steroidsensiblen nephrotischen Syndroms im Kindesalter. Der Nephrologe 10: 462-471. View at Publisher | View at Google Scholar
| View at Indexing
-
Kemper MJ, Müller-Wiefel DE, Tönshoff B (2015) Nephrotisches Syndrom bei Kindern. Der Nephrologe 10: 368-372. View at Publisher | View at Google Scholar
| View at Indexing
-
Buenrostro D, Park SI, Sterling JA. Dissecting the role of bone marrow stromal cells on bone metastases. BioMed research international. 2014 Jun 26;2014.
View at Publisher | View at Google Scholar
-
Chang AB, O'Grady KA(2014) Clinical trials in pediatrics. Clinical Investigation 4:981-983. View at Publisher | View at Google Scholar
| View at Indexing
-
Rösel D, Brábek J, Veselý P, Fernandes M. Drugs for solid cancer: the productivity crisis prompts a rethink. Onco Targets Ther. 2013 Jun 1;6:767-7.
View at Publisher | View at Google Scholar
-
Zanni, Riccardo (2015) Molecular topology design and pharmacological assays of new inhibitors against WNT / β-CATENIN AND PI3K / Akt / Mtor. Clinical medical sciences 32:1591 View at Publisher | View at Google Scholar
| View at Indexing
-
Su B, Gillard B, Gao L, Eng KH, Gelman IH. Src controls castration recurrence of CWR22 prostate cancer xenografts. Cancer medicine. 2013 Dec 1;2(6):784-92.
View at Publisher | View at Google Scholar
-
Wei J, Wang Z, Makarov D, Li X. Current treatments and novel therapeutic targets for castration resistant prostate cancer with bone metastasis. American journal of clinical and experimental urology. 2013;1(1):30.
View at Publisher | View at Google Scholar
-
Zargaran M, Moghimbeigi A, Afsharmoghadam N, Isfahani MN, Hashemi A. A Comparative Study of Cathepsin D Expression in Peripheral and Central Giant Cell Granuloma of the Jaws by Immunohistochemistry Technique. Journal of Dentistry. 2016 Jun;17(2):98.
View at Publisher | View at Google Scholar
-
Koiwa F, Terao A. Dose–response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study. Clinical and experimental nephrology. 2016 Jul 7:1-0. View at Publisher | View at Google Scholar
| View at Indexing
-
Chirgwin JM, Roodman GD. Pathophysiology of bone metastases. InBone Metastases 2014 (pp. 3-17). Springer Netherlands.
View at Publisher | View at Google Scholar
-
Marcuccilli M, Chonchol M, Jovanovich A. Phosphate binders and targets over decades: do we have it right now?. InSeminars in dialysis 2017 Mar (Vol. 30, No. 2, pp. 134-141). View at Publisher | View at Google Scholar
| View at Indexing
-
Hou Q, Gong R, Liu X, Mao H, Xu X, Liu D, Dai Z, Wang H, Wang B, Hu C. Poly I: C facilitates the phosphorylation of Ctenopharyngodon idellus type I IFN receptor subunits and JAK kinase. Fish & Shellfish Immunology. 2017 Jan 31;60:13-20.
View at Publisher | View at Google Scholar
-
éâ¢Ëæâ¢âèâ¢Å½, Ã¥Ââ¢Ã§âÅéšâ , 骞ç˱è£, æÂŽäº¬å®Â, Ã¥â¢â 澎. 破骨ç»â èÆÅ¾Ã§Å¡âå½¢æËÂÃ¥âÅæ´»åÅâç âç©¶è¿âºÃ¥Â±â¢. ä¸ÂÃ¥âºÂ½Ã§Â»â èÆÅ¾Ã§âŸçâ°Â©Ã¥Â¦å¦报. 2014;36(2):258-66.
View at Publisher | View at Google Scholar
-
Khalil DN, Budhu S, Gasmi B, Zappasodi R, Hirschhorn-Cymerman D, Plitt T, De Henau O, Zamarin D, Holmgaard RB, Murphy JT, Wolchok JD. The new era of cancer immunotherapy: manipulating T-cell activity to overcome malignancy. Advances in cancer research. 2015 Jan 1;128:1-68. View at Publisher | View at Google Scholar
| View at Indexing
-
Tavakoli I. Inhibition of castration resistant prostate cancer by sintokamide A: an antagonist of the amino-terminus of the androgen receptor (Doctoral dissertation, University of British Columbia).
View at Publisher | View at Google Scholar
-
Herson J. Data and safety monitoring committees in clinical trials. CRC Press; 2016 Dec 19. View at Publisher | View at Google Scholar
| View at Indexing
-
Timmermans, Catherine, et al. "Statistical monitoring of data quality and consistency in the Stomach Cancer Adjuvant Multi-institutional Trial Group Trial." Gastric Cancer 19.1 (2016): 24-30. View at Publisher | View at Google Scholar
| View at Indexing
-
George SL. Research misconduct and data fraud in clinical trials: prevalence and causal factors. International journal of clinical oncology. 2016 Feb 1;21(1):15-21. View at Publisher | View at Google Scholar
| View at Indexing
-
Timmermans C, Venet D, Burzykowski T. Data-driven risk identification in phase III clinical trials using central statistical monitoring. International journal of clinical oncology. 2016 Feb 1;21(1):38-45. View at Publisher | View at Google Scholar
| View at Indexing
-
Buyse M, Evans SJ. Fraud in clinical trials. Wiley StatsRef: Statistics Reference Online. 2001. View at Publisher | View at Google Scholar
| View at Indexing
-
Herson J. Strategies for dealing with fraud in clinical trials. International journal of clinical oncology. 2016 Feb 1;21(1):22-7. View at Publisher | View at Google Scholar
| View at Indexing
-
Wurdinger T, Deumelandt K, van der Vliet HJ, Wesseling P, de Gruijl TD. Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2014 Dec 31;1846(2):560-75.
View at Publisher | View at Google Scholar
-
Sakamoto J. A Hercule Poirot of clinical research. View at Publisher | View at Google Scholar
| View at Indexing
-
Zhang J, Wu H, Li P, Zhao Y, Liu M, Tang H. NF-κB-modulated miR-130a targets TNF-α in cervical cancer cells. Journal of translational medicine. 2014 Jun 1;12(1):155.
View at Publisher | View at Google Scholar
-
Zhang J, Wu H, Li P, Zhao Y, Liu M, Tang H. NF-κB-modulated miR-130a targets TNF-α in cervical cancer cells. Journal of translational medicine. 2014 Jun 1;12(1):155.
View at Publisher | View at Google Scholar
-
Hartgerink C, George S. Problematic trial detection in ClinicalTrials. gov. Research Ideas and Outcomes. 2015 Dec 17;1:e7462. View at Publisher | View at Google Scholar
| View at Indexing
-
Greenland S. For and Against Methodologies: Some Perspectives on Recent Causal and Statistical Inference Debates. European Journal of Epidemiology.:1-8. View at Publisher | View at Google Scholar
| View at Indexing
-
Yang O, Jianhua H, Lin S. Regulatory effects of miRNA on gastric cancer cells. Oncology letters. 2014 Aug 1;8(2):651-6.
View at Publisher | View at Google Scholar
-
Keller S, Korkmaz G, Orr M, Schroeder A, Shipp S. The Evolution of Data Quality: Understanding the Transdisciplinary Origins of Data Quality Concepts and Approaches. Annual Review of Statistics and Its Application. 2016 Jun 30(0). View at Publisher | View at Google Scholar
| View at Indexing
-
韩èââ, 石æËŸ, éâ¢â Ã¥ÂÂé¹Â, 顾çŽâ°Ã©Ââ, é«Ëæââ¡Ã¦Â¶âº. èâ¡ÂªÃ¥Ââæâ¬Â§ 1 åžâ¹Ã§Â³âå°¿çâ⦠NOD å°Âé¼ èÆÂ°Ã¨â¦ÂºÃ¥Â¾Â®Ã¥Â°Â RNA 表达谱åËâ æžÂ. ä¸ÂåŽç³âå°¿çââ¦Ã¦Ââå¿â. 2013;5(7):398-402.
View at Publisher | View at Google Scholar
-
Johnston J, Banerjee MP, Geller G. Trustworthy Research Institutions: The Challenging Case of Studying theGenetics of Intelligence. Hastings Center Report. 2015 Sep 1;45(S1):S59-65. View at Publisher | View at Google Scholar
| View at Indexing
-
King M. Detecting counterfeit data in clinical trials.
View at Publisher | View at Google Scholar
-
Casaluce F, Sgambato A, Claudia Sacco P, Palazzolo G, Maione P, Rossi A, Ciardiello F, Gridelli C. Resistance to crizotinib in advanced non-small cell lung cancer (NSCLC) with ALK rearrangement: mechanisms, treatment strategies and new targeted therapies. Current clinical pharmacology. 2016 May 1;11(2):77-87. View at Publisher | View at Google Scholar
| View at Indexing
-
Liu R, Wang S, Fang S, Wang J, Chen J, Huang X, He X, Liu C. Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation. Nanoscale research letters. 2016 May 17;11(1):254. View at Publisher | View at Google Scholar
| View at Indexing
-
Josephy-Hernandez S, Jmaeff S, Pirvulescu I, Aboulkassim T, Saragovi HU. Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm. Neurobiology of Disease. 2017 Jan 31;97:139-55. View at Publisher | View at Google Scholar
| View at Indexing
-
Madden L. Recommending dry eye treatments in community pharmacy. Sepsis. 2017 Jan 16;17:07.
View at Publisher | View at Google Scholar
-
Chennell P, Delaborde L, Wasiak M, Jouannet M, Feschet-Chassot E, Chiambaretta F, Sautou V. Stability of an ophthalmic micellar formulation of cyclosporine A in unopened multidose eyedroppers and in simulated use conditions. European Journal of Pharmaceutical Sciences. 2017 Mar 30;100:230-7. View at Publisher | View at Google Scholar
| View at Indexing
-
Chao SC, Nien CW, Iacob C, Hu DN, Huang SC, Lin HY. Effects of Lutein on Hyperosmoticity-Induced Upregulation of IL-6 in Cultured Corneal Epithelial Cells and Its Relevant Signal Pathways. Journal of ophthalmology. 2016 Mar 7;2016. View at Publisher | View at Google Scholar
| View at Indexing
-
Downing AM, Yaari R, Ball DE, Selzler KJ, Devous Sr MD. BRIDGING THE GAP BETWEEN RESEARCH AND CLINICAL PRACTICE IN ASYMPTOMATIC ALZHEIMER’S DISEASE.
View at Publisher | View at Google Scholar
-
Bachurin SO, Bovina EV, Ustyugov AA. Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends. Medicinal Research Reviews. 2017 Jan 1.
View at Publisher | View at Google Scholar
-
Antonijevic Z. Adaptive Clinical Trials. Clinical Investigation. 2015 Apr;5(4):353-4.
View at Publisher | View at Google Scholar
-
Antonijevic Z. Adaptive Clinical Trials. Clinical Investigation. 2015 Apr;5(4):353-4.
View at Publisher | View at Google Scholar
-
Antonijevic Z. Adaptive Clinical Trials. Clinical Investigation. 2015 Apr;5(4):353-4.
View at Publisher | View at Google Scholar
-
Fang W. Modeling Arbitrarily Interval-Censored Survival Data with External Time-Dependent Covariates. UNIVERSITY OF NORTHERN COLORADO; 2015.
View at Publisher | View at Google Scholar